870 A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC)

Autor:	D. Petrylak, D.C. Smith, L.J. Appleman, M. Fleming, A. Hussain, R. Dreicer, O. Sartor, N. Shore, N. Vogelzang, H. Youssoufian, N. Stambler, K. Huang, R.J. Israel
Rok vydání:	2014
Předmět:	Urology
Zdroj:	European Urology Supplements. 13:e870
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(14)60857-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::edc62c211c702880795b379bd22facc4 https://doi.org/10.1016/s1569-9056(14)60857-5 Zobrazit plný text záznamu Full Text from ScienceDirect